Literature DB >> 33858822

Optimal Duration of MRI Follow-up to Safely Identify Middle Ear Residual Cholesteatoma.

A-L Fourez1, M Akkari1, G Gascou2, P-H Lefevre2, C Duflos3, A Kaderbay1, M Mondain1, F Venail4,5.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies have demonstrated the usefulness of non-EPI DWI for detection of residual cholesteatoma. However, limited data are available to determine the suitable duration of imaging follow-up after a first MR imaging with normal findings has been obtained. The present study aimed to determine the optimal duration of non-EPI DWI follow-up for residual cholesteatoma.
MATERIALS AND METHODS: A retrospective, monocentric study was performed between 2013 and 2019 and included all participants followed up after canal wall up tympanoplasty with at least 2 non-EPI DWI examinations performed on the same 1.5T MR imaging scanner. MR images were reviewed independently by 2 radiologists. Sensitivity and specificity values were calculated as a function of time after the operation. Receiver operating characteristic curves were analyzed to determine the optimal follow-up duration.
RESULTS: We analyzed 47 MRIs from 17 participants. At the end of the individual follow-up period, a residual cholesteatoma had been found in 41.1% of cases. The follow-up duration ranged from 20 to 198 months (mean, 65.9 [SD, 43.9] months). Participants underwent between 2 and 5 non-EPI DWI examinations. Analyses of the receiver operating characteristic curves revealed that the optimal diagnostic value of non-EPI DWI occurred 56 months after the operation when the first MR imaging performed a mean of 17.3 (SD, 6.8) months after the operation had normal findings (sensitivity = 0.71; specificity = 0.7, Youden index = 0.43).
CONCLUSIONS: Repeat non-EPI DWI is required to detect slow-growing middle ear residual cholesteatomas. We, therefore, recommend performing non-EPI DWI for at least the first 5 years after the initial operation.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2021        PMID: 33858822      PMCID: PMC8324276          DOI: 10.3174/ajnr.A7116

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  18 in total

1.  A Meta-Analysis on the Diagnostic Performance of Non-Echoplanar Diffusion-Weighted Imaging in Detecting Middle Ear Cholesteatoma: 10 Years On.

Authors:  Ravi K Lingam; Paul Bassett
Journal:  Otol Neurotol       Date:  2017-04       Impact factor: 2.311

2.  Repeated Postoperative Follow-up Diffusion-weighted Magnetic Resonance Imaging to Detect Residual or Recurrent Cholesteatoma.

Authors:  Stefan Steens; Wulphert Venderink; Dirk Kunst; Anton Meijer; Emmanuel Mylanus
Journal:  Otol Neurotol       Date:  2016-04       Impact factor: 2.311

3.  The value of non-echo planar HASTE diffusion-weighted MR imaging in the detection, localisation and prediction of extent of postoperative cholesteatoma.

Authors:  S Khemani; R K Lingam; A Kalan; A Singh
Journal:  Clin Otolaryngol       Date:  2011-08       Impact factor: 2.597

4.  Growth rate and recurrence of residual epidermoid cholesteatoma after tympanoplasty.

Authors:  R E Gristwood; W N Venables
Journal:  Clin Otolaryngol Allied Sci       Date:  1976

5.  Magnetic resonance imaging at one year for detection of postoperative residual cholesteatoma in children: Is it too early?

Authors:  A Lecler; M Lenoir; J Peron; F Denoyelle; E N Garabedian; H Ducou le Pointe; J Nevoux
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-05-29       Impact factor: 1.675

Review 6.  EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.

Authors:  Matthew Yung; Tetsuya Tono; Ewa Olszewska; Yutaka Yamamoto; Holger Sudhoff; Masafumi Sakagami; Jef Mulder; Hiromi Kojima; Armağan İncesulu; Franco Trabalzini; Nuri Özgirgin
Journal:  J Int Adv Otol       Date:  2017-01-06       Impact factor: 1.017

7.  Negative Predictive Value of Non-Echo-Planar Diffusion Weighted MR Imaging for the Detection of Residual Cholesteatoma Done at 9 Months After Primary Surgery Is not High Enough to Omit Second Look Surgery.

Authors:  Roelof J Horn; Jan Willem C Gratama; Hester J van der Zaag-Loonen; Kitty E Droogh-de Greve; Peter-Paul G van Benthem
Journal:  Otol Neurotol       Date:  2019-08       Impact factor: 2.311

8.  Middle ear cholesteatoma: Compared diagnostic performances of two incremental MRI protocols including non-echo planar diffusion-weighted imaging acquired on 3T and 1.5T scanners.

Authors:  J Lincot; F Veillon; S Riehm; N Babay; J-F Matern; B Rock; B Dallaudière; N Meyer
Journal:  J Neuroradiol       Date:  2014-07-09       Impact factor: 3.447

9.  Giant Cholesteatoma: Recommendations for Follow-up.

Authors:  Leontien I Geven; Jef J S Mulder; Kees Graamans
Journal:  Skull Base       Date:  2008-09

10.  Diffusion-weighted magnetic resonance imaging in the detection of residual and recurrent cholesteatoma in children: A systematic review and meta-analysis.

Authors:  Khalil Bazzi; Eugene Wong; Nicholas Jufas; Nirmal Patel
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2018-12-26       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.